Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000373573

Medchemexpress LLC Leritrelvir (RAY1216) | 2923310-64-7 | C31H44F3N5O6 | 5 MG
SDP

Catalog No. 5000373573
Encompass_Preferred

Leritrelvir (RAY1216) is an orally active SARS-CoV-2 main protease slow-tight inhibitor with a Ki of 8.6 nM. It is for research use only and not sold to patients.

  • Orally active SARS-CoV-2 main protease slow-tight inhibitor
  • Potent inhibitor with a Ki of 8.6 nM
  • Covalently attaches to the catalytic Cys145
  • Demonstrates antiviral activities against SARS-CoV-2 wild type ancestral strain and variants
  • Effectively prolongs survival in SARS-CoV-2 infected mice models
  • Reduces virus-induced pathology in animal models
  • Exhibits a promising human pharmacokinetics profile

Catalog No. 50-003-73573 Supplier Medchemexpress LLC Supplier No. HY1531215MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Leritrelvir (RAY1216) is an orally active SARS-CoV-2 main protease slow-tight inhibitor with a Ki of 8.6 nM. It is for research use only and not sold to patients.

  • Orally active SARS-CoV-2 main protease slow-tight inhibitor
  • Potent inhibitor with a Ki of 8.6 nM
  • Covalently attaches to the catalytic Cys145
  • Demonstrates antiviral activities against SARS-CoV-2 wild type ancestral strain and variants
  • Effectively prolongs survival in SARS-CoV-2 infected mice models
  • Reduces virus-induced pathology in animal models
  • Exhibits a promising human pharmacokinetics profile

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.